Blog

Health X Revenue break up

[Stock idea]: Health X Platform – India’s Online Pharmacy Play: ₹1,300 Cr Revenue, targeting ₹6,000 Cr

The Indian pharma distribution market is a ₹5 lakh crore opportunity by FY28. Most investors are chasing listed retail pharmacy chains. But there’s a less-noticed digital-first player quietly building the supply chain backbone behind 62,000 retail pharmacies — while also running a B2C online pharmacy app. That company is Health X Platform Limited (NSE: HEALTHX), formerly Sastasundar Ventures. Here are my notes, but before that: Help us grow: If you think our stock recommendations could add value to your friends, relatives,…

Read More
red flag issues

Your 15 minute portfolio audit (this weekend)

This weekend task: 15 minutes per holding Open latest annual report. Check for these 10 red flags. If you find 3+ on any stock → Dig deeper or exit. Before that, Help us grow: If our research adds value to your investing process, we’d appreciate you spreading the word about Katalyst Wealth to friends, family, or colleagues who might benefit.   Latest Stock recommendations for Premium Members: Alpha & Alpha+ (Released: 2nd Jun ’26) A first-mover in a $7 billion global recycling…

Read More
co recycling waste model

[Stock idea]: Eco Recycling – India’s E-waste Pioneer Just Posted Its Best Quarter Ever 🌱

India generates 6.19 million tonnes of e-waste every year — and only 11% of it gets collected properly. One company has been solving this problem since before most people even knew it was a problem. Eco Recycling Limited (Ecoreco), India’s first e-waste recycler, just filed its Q4 FY26 results — and the numbers are hard to ignore. Here are my notes, but before that: Help us grow: If you think our stock recommendations could add value to your friends, relatives, or…

Read More
Dhabriya product profile

[Stock idea]: A ₹264 Cr company targeting 30% CAGR — here’s what management said

Most investors haven’t heard of Dhabriya Polywood. But after going through their Q4 FY26 earnings call, I think that’s about to change. The numbers are clean. The story is sharper. And management is making some interesting moves. Here are my notes from the concall — the key numbers, the growth levers, and a few things worth watching closely, but before that: Help us grow: If you think our stock recommendations could add value to your friends, relatives, or acquaintances, we’d appreciate you…

Read More